BFA Treatment of Pain
Completed · Not applicable
Conditions studied: Musculoskeletal Pain, Acute Pain
In brief
The aim of this pilot study is to conduct an unblinded pilot randomized clinical study on the effectiveness and tolerability of auricular semi-permanent (ASP) vs intradermal (long), and pyonex needles in Battlefield Acupuncture (BFA) for the treatment of pain.
Key facts
- Study ID
- NCT04464954
- Run by
- Paul Crawford
- People needed
- 30
- Starts
- 2020-11-01
- Expected to finish
- 2021-04-20
- Last updated by the study team
- 2024-04-04
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Active duty and DoD Beneficiaries aged 18 years or older
- Acute (0-4 days) musculoskeletal injury
- Injuries eligible for inclusion include all acute non-fracture related musculoskeletal injuries of the axial or peripheral skeleton.
You may not qualify if…
- Taking any opioid medications daily
- Rheumatologic and autoimmune conditions which may be creating pain, such as rheumatoid arthritis, advanced osteoarthritis, or spinal stenosis
- Contra-indication to needle use including known bleeding disorder and psychogenic issues related to needle use (e.g., needle-phobia)
- Evidence or history of clinically significant immune deficiency, hematological, oncological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or severe allergic disease (including to metals and adhesive tapes) which could interfere with this study
- Individuals with progressive radiating pain with motor-sensory changes (including weakness or numbness) related to their presenting pain complaint
- Women who are pregnant, may be pregnant, or attempting to become pregnant
Where it is running
- Mike O'Callaghan Military Medical Center — Nellis Air Force Base, Nevada, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.